Research Article
A Network Pharmacology Approach to Investigate the Active Compounds and Mechanisms of Musk for Ischemic Stroke
Table 3
KEGG enrichment analysis was performed on core targets.
| Category | Term | Count | P value |
| KEGG PATHWAY | hsa04668: TNF signaling pathway | 18 | 3.55E − 15 | KEGG PATHWAY | hsa04915: estrogen signaling pathway | 17 | 1.87E − 14 | KEGG PATHWAY | hsa04917: prolactin signaling pathway | 14 | 1.23E − 12 | KEGG PATHWAY | hsa04722: neurotrophin signaling pathway | 16 | 6.49E − 12 | KEGG PATHWAY | hsa04660: T-cell receptor signaling pathway | 15 | 7.24E − 12 | KEGG PATHWAY | hsa04024: cAMP signaling pathway | 19 | 9.88E − 12 | KEGG PATHWAY | hsa04068: FoxO signaling pathway | 16 | 3.29E − 11 | KEGG PATHWAY | hsa04066: HIF-1 signaling pathway | 14 | 6.72E − 11 | KEGG PATHWAY | hsa04932: nonalcoholic fatty liver disease (NAFLD) | 15 | 2.01E − 09 | KEGG PATHWAY | hsa04015: Rap1 signaling pathway | 17 | 2.26E − 09 |
|
|